[This corrects the article on p. e73195 in vol. 8.].
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3790883 | PMC |
| http://dx.doi.org/10.1371/annotation/9ae8db84-5d44-4a9c-bb80-47c9d68820ea | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Correction: CD44 standard and CD44v10 isoform expression on leukemia cells distinctly influences niche embedding of hematopoietic stem cells.
J Hematol Oncol
December 2024
Department of Tumor Cell Biology, University Hospital of Surgery, Heidelberg, Germany.
Identification of metabolic reprogramming-related genes as potential diagnostic biomarkers for diabetic nephropathy based on bioinformatics.
Diabetol Metab Syndr
November 2024
Department of Endocrinology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Background: Diabetic nephropathy (DN) is a serious complication of diabetes mellitus, marked by progressive renal damage. Recent evidence indicates that metabolic reprogramming is crucial to DN pathogenesis, yet its underlying mechanisms are not well understood. This study aimed to examine how metabolic reprogramming-related genes (MRRGs) are differentially expressed and to explore their potential mechanisms in the development of DN.
View Article and Find Full Text PDFCorrection: Cytomembrane-mimicking nanocarriers with a scaffold consisting of a CD44-targeted endogenous component for effective asparaginase supramolecule delivery.
Nanoscale
December 2024
Chongqing Research Center for Pharmaceutical Engineering, Chongqing Medical University, Chongqing 400016, China.
Article Synopsis
- The research focuses on developing nanocarriers that mimic cell membranes to enhance the delivery of asparaginase, an enzyme used in cancer treatment.
- These nanocarriers incorporate a scaffold targeted to CD44, a receptor often overexpressed in cancer cells, enabling more effective drug delivery.
- The study demonstrates that these engineered nanocarriers can improve therapeutic outcomes by increasing the concentration of asparaginase at tumor sites while reducing side effects.
Corrigendum: Exosomal CD44 transmits lymph node metastatic capacity between gastric cancer cells via YAP-CPT1A-mediated FAO reprogramming.
Front Oncol
October 2024
Key Laboratory of Medical Science and Laboratory Medicine of Jiangsu Province, School of Medicine, Jiangsu University, Zhenjiang, China.
[This corrects the article DOI: 10.3389/fonc.2022.
View Article and Find Full Text PDFThe post-viral GPNMB immune niche persists in long-term Covid, asthma, and COPD.
medRxiv
August 2024
Pulmonary and Critical Care Medicine, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA 63110.
Article Synopsis
- Epithelial cells, which help protect our body, need help from stem cells and immune cells to heal when they're hurt, especially after infections like viruses.
- Researchers found out that special immune cells (called moDCs) help these epithelial stem cells repair and may lead to long-term health issues if not controlled.
- They discovered a marker called GPNMB in lung cells from people with conditions like long Covid, asthma, and COPD, which might help understand and treat chronic diseases better.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!